Literaturverzeichnis
zum Titelthema „Viszeralmedizin – highlighted“
von Professor Dr. Jens Werner, Privatdozent Dr. Jan D‘Haese und Privatdozent Dr. Tobias Schiergens
Bayerisches Ärzteblatt 12/2019, Seite 632 ff.
1. L. Leifeld CG, S. Böhm, FL. Dumoulin, W. Häuser, ME. Kreis, J. Labenz, B. Lembcke, S. Post, M. Reinshagen, JP. Ritz, T. Sauerbruch, T. Wedel, BHA von Rahden, W. Kruis:
S2k Leitlinie Divertikelkrankheit / Divertikulitis. 2014.
2. Gatermann SK, M.; Kern, W. V.: Antibiotika-Empfindlichkeit: Grenzwerte sind hilfreich.
Dtsch Arztebl 2017;114(26): A-1314 / B-1094 / C-1072.
3. Schiergens TS, von Einem J, Thomas MN, et al.: Multidisciplinary treatment of colorectal liver metastases. Minerva Med 2017;108:527-546.
4. Phillips JD, Hasson RM: Surgical management of colorectal lung metastases. J Surg Oncol 2019;119:629-635.
5. Rentsch M, Schiergens TS: Treatment plan improvement by multidisciplinary case conferences for patients with colorectal cancer and synchronous liver metastases.
Hepatobiliary Surg Nutr 2018;7:147-148.
6. Bonjer HJ, Deijen CL, Haglind E, Group CIS: A Randomized Trial of Laparoscopic versus Open Surgery for Rectal Cancer. N Engl J Med 2015;373:194.
7. Jeong SY, Park JW, Nam BH, et al.: Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival
outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol 2014;15:767-774.
8. Prete FP, Pezzolla A, Prete F, et al.: Robotic Versus Laparoscopic Minimally Invasive Surgery for Rectal Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Ann Surg 2018;267:1034-1046.
9. Jayne D, Pigazzi A, Marshall H, et al.: Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial.
JAMA 2017;318:1569-1580.
10. Kneist W, Kauff DW, Juhre V, et al.: Is intraoperative neuromonitoring associated with better functional outcome in patients undergoing open TME? Results of a case-control study. Eur J Surg Oncol 2013;39:994-999.
11. Heiliger C, Piecuch J, Frank A, et al.: Intraarterial indocyanine green (ICG) fluorescence augmentation by marking embryonal resection areas in colorectal surgery: a feasibility study in a porcine model. Minim Invasive Ther Allied Technol 2018:1-5.
12. Magdassi S, Bar-David S, Friedman-Levi Y, et al.: Intraoperative Localization of Rectal Tumors Using Liposomal Indocyanine Green. Surg Innov 2017;24:139-144.
13. Boni L, Fingerhut A, Marzorati A, et al.: Indocyanine green fluorescence angiography during laparoscopic low anterior resection: results of a case-matched study. Surg Endosc 2017;31:1836-1840.
14. M. Tanaka, C. Fernandez-Del Castillo, T. Kamisawa, J. Y. Jang, P. Levy, T. Ohtsuka, R. Salvia, Y. Shimizu, M. Tada, C. L. Wolfgang, Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology.
2017;17(5): p. 738-753.
15. J. J. Farrell, C. Fernandez-del Castillo, Pancreatic cystic neoplasms: management and unanswered questions. Gastroenterology. 2013;144(6): p. 1303-15.
16. J. Werner, S. Fritz, M. W. Buchler, Intraductal papillary mucinous neoplasms of the pancreas--a surgical disease. Nat Rev Gastroenterol Hepatol. 2012;9(5): p. 253-9.
17. J.G. D'Haese, J. Werner, Surgery of cystic tumors of the pancreas - why, when, and how? Visc Med 2018; 34: 206-210.
